%D8%B1%D9%8A%D8%B3%D8%A8%D9%8A%D8%B1%D9%8A%D8%AF%D9%88%D9%86%D8%B1%DB%8C%D8%B3%D9%BE%D8%B1%DB%8C%D8%AF%D9%88%D9%86%D0%A0%D1%8B%D1%81%D0%BF%D0%B5%D1%80%D1%8B%D0%B4%D0%BE%D0%BD%D0%A0%D0%B8%D1%81%D0%BF%D0%B5%D1%80%D0%B8%D0%B4%D0%BE%D0%BDRisperidonaCategory:RisperidoneRisperidonRisperidonRisperidon%CE%A1%CE%B9%CF%83%CF%80%CE%B5%CF%81%CE%B9%CE%B4%CF%8C%CE%BD%CE%B7RisperidoneRisperidona%D8%B1%DB%8C%D8%B3%D9%BE%D8%B1%DB%8C%D8%AF%D9%88%D9%86RisperidoniRisp%C3%A9ridone%D7%A8%D7%99%D7%A1%D7%A4%D7%A8%D7%99%D7%93%D7%95%D7%9F%E0%A4%B0%E0%A4%BF%E0%A4%B8%E0%A4%AA%E0%A5%87%E0%A4%B0%E0%A5%80%E0%A4%A1%E0%A5%8B%E0%A4%A8RiszperidonRisperidone%E3%83%AA%E3%82%B9%E3%83%9A%E3%83%AA%E3%83%89%E3%83%B3%EB%A6%AC%EC%8A%A4%ED%8E%98%EB%A6%AC%EB%8F%88RisperidonumRisperidon%E0%AC%B0%E0%AC%BF%E0%AC%B8%E0%AC%AA%E0%AD%87%E0%AC%B0%E0%AC%BF%E0%AC%A1%E0%AC%A8RysperydonRisperidonaRisperidon%C4%83%D0%A0%D0%B8%D1%81%D0%BF%D0%B5%D1%80%D0%B8%D0%B4%D0%BE%D0%BDRisperidonRisperidone%D0%A0%D0%B8%D1%81%D0%BF%D0%BE%D0%BB%D0%B5%D0%BF%D1%82Risperidon%E0%B8%A3%E0%B8%B4%E0%B8%AA%E0%B9%80%E0%B8%9E%E0%B8%AD%E0%B8%A3%E0%B8%B4%E0%B9%82%E0%B8%94%E0%B8%99%D0%A0%D0%B8%D1%81%D0%BF%D0%B5%D1%80%D0%B8%D0%B4%D0%BE%D0%BDRisperidoneQ412443%E7%B6%AD%E6%80%9D%E9%80%9A
about
5-hydroxytryptamine receptor 2ADopamine receptor D25-hydroxytryptamine receptor 2C5-hydroxytryptamine receptor 75-hydroxytryptamine receptor 6Dopamine receptor D35-hydroxytryptamine receptor 1A5-hydroxytryptamine receptor 1D5-hydroxytryptamine receptor 1E5-hydroxytryptamine receptor 1F5-hydroxytryptamine receptor 1BHistamine receptor H1Adrenoceptor alpha 1AAdrenoceptor alpha 1BAdrenoceptor alpha 1D
P129
Alzheimer's diseaseimpulse control disordermental disorderbipolar disorderoppositional defiant disorderanxietypsychosisobsessive-compulsive disorderintellectual disabilityintermittent explosive disorderinsomniamood disorderTourette syndromepost-traumatic stress disorderRisperidone treatment for cocaine abusepersonality disorderautismschizophreniabipolar I disorderanxiety disordersleep-wake disorderconduct disorderpervasive developmental disorderdementiaschizoaffective disorder
P2176
P3781
A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersStudy to Evaluate the Efficacy and Safety of Risperidone ISMĀ® in Patients With Acute SchizophreniaA Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic SchizophreniaBioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese PatientsMedical Chart Review of Patients on Long-term Treatment With Long-acting Injectable RisperidoneLurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaQuetiapine Extended Release Depression SymptomsEfficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With SchizophreniaLow-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality DisorderA Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.Antipsychotic Polypharmacy in SchizophreniaManaging Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsComparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderZotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute WardAntipsychotic Discontinuation in Alzheimer's DiseaseComparison of Applied Behavioral Analysis (ABA) Versus ABA and RisperidoneTreatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisStudy Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointSPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With SchizophreniaEvaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in IsraelOral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaStudy on the Safety of Risperidone on Obese or Overweight Patients With SchizophreniaUse of Galantamine and CDP-choline (Citicoline) to Treat Adults With SchizophreniaA Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeEfficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaThe Effects of Risperidone and Olanzapine on ThinkingStudy Of Talnetant Versus Placebo And Risperidone In SchizophreniaInvestigate Risperidone for the Treatment of Schizophrenia in AdolescentsStudy Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment RegimeEfficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaIs Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar DisorderAn Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)Ginkgo Biloba Extract for SchizophreniaEfficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and AmenorrheaPhase IIb-III Study of BL-1020 Small Molecule for SchizophreniaBiomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)Safety and Efficacy of Zicronapine in Patients With Schizophrenia
P4844
Risperidone in long-term treatment for bipolar disorderRisperidone alone or in combination for acute maniaAcute and long-term treatment of catatonia with risperidone.Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.Long-acting risperidone: a review of its use in schizophrenia.Risperidone in the treatment of bipolar mania.Pharmacogenetics of clinical response to risperidone.Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.An evaluation of risperidone drug interactions.Risperidone in the treatment of patients with delirium.Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.Nicotinic Receptors and Schizophrenia (2015-08-31)Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone ImplantSafety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant
P921
Q1949517-5307E354-A833-4759-BC14-115D3849DBC0Q2034004-C21E859B-B241-4764-A1AE-C531B74E5005Q21108118-1A2C29B7-235A-4C19-903A-F5E4B5C748FBQ21109355-33ED63C2-13D4-4E4D-BEF2-D400E5104390Q21109363-75F05D4D-E39C-43B7-B994-3580C97405EAQ21110872-F7E07EB8-BC35-4F83-B6B6-28244CFC7322Q21115043-1A64B7E8-6D33-40DF-AB13-DC9F6ABDDD1DQ21115046-50A6C0B7-6627-4031-9015-98DB1132BD3CQ21115051-C135E528-A9E9-4625-8BD1-E7EDC2C952BBQ21115052-7BA5CCD8-EC7C-4D1B-B11C-D824C7A4D3A1Q288797-999887D1-F328-4A99-930A-B48B17AA6A45Q309513-CCF9D6E7-EE22-43C3-8460-5EB61FFF18C5Q4734884-9C25872F-9F08-4F3F-9EE1-2060F9721E7AQ4734886-46EAA980-9D51-4254-88BC-682C5C2160E3Q4734887-9354B1FD-9F8B-47A6-AB9B-B3E8F86990B6
P129
Q11081-3570C71D-1DAE-450D-B8A2-302812FC88A5Q1201835-76C1B6F4-53F2-4291-88EA-83E350ED11D1Q12135-9C9CAA57-AC75-47DF-A89E-EB399FEFCF3CQ131755-462097AF-0144-4EEE-8DDE-F6E3462C7080Q1328833-41214F8F-80E2-406F-A82D-6B73854C2F1AQ154430-AB3DAB8A-B629-46B7-A8C5-8D245E6036D8Q170082-EDC57507-A541-470D-91F9-DC2812A3DCB1Q178190-FBF4D044-AA6B-4FD7-B002-0952D0025ADFQ183560-26CB3A1C-D8CC-4925-B87B-EE26C4BADC66Q18671-EE5C2458-04F7-4014-B8EF-08EDD893BCADQ1869874-E9638D5F-7513-4301-BCF8-3AB604EE9C4BQ188638-64475FA7-8B62-4B50-BCEB-8D6E4B84F432Q191779-523E3DDB-1FC4-4A97-B594-6806877D92C0Q202387-023BAEC9-FAA6-4AED-9757-545067E9EEE9Q26715035-5cd3fa08-4ef8-87bd-c104-0c003426514bQ270673-8B42E7A5-020F-4DEF-97C3-658777565991Q38404-373E523F-A375-48A5-BE64-54AB15E2741DQ38404-CE9BE347-586E-4E0B-AF35-4A3B30A0AE82Q41112-93F774EE-E342-4EF7-B18C-B50CDDEE2D2FQ4915474-FD161703-06C9-4F1A-A885-902A42B2EAFDQ544006-4DF5A279-06A3-44CA-AED6-121CD464103BQ54972453-8B878048-9F74-44AC-B162-C19C0AF424D1Q596474-0B66CF74-D6F4-4487-96E1-94242EF897A1Q6691991-C678AFD3-D6E0-4DA3-BA73-3CCA95BF3354Q83030-596BD7FC-AC29-4FA9-9800-C10C01EB63FFQ834047-7CA0E085-76C3-496B-BEDD-1F7A9CB8C570
P2176
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemickĆ” slouÄenina
@cs
chemickĆ” zlĆŗÄenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Risperidon
@da
Risperidon
@de
Risperidon
@nl
Risperidon
@pl
Risperidon
@sh
Risperidon
@sv
Risperidone
@vi
Risperidoni
@fi
Risperidonum
@la
Rispolept
@sr-el
type
label
Risperidon
@da
Risperidon
@de
Risperidon
@nl
Risperidon
@pl
Risperidon
@sh
Risperidon
@sv
Risperidone
@vi
Risperidoni
@fi
Risperidonum
@la
Rispolept
@sr-el
altLabel
106266-06-2
@fr
Belivon
@es
Belivon
@nl
C23H27FN4O2
@fr
C23H27FN4O2
@it
Neuroperidon
@de
R-64-766
@cy
R-64-766
@en
R-64766
@cy
R-64766
@en
prefLabel
Risperidon
@da
Risperidon
@de
Risperidon
@nl
Risperidon
@pl
Risperidon
@sh
Risperidon
@sv
Risperidone
@vi
Risperidoni
@fi
Risperidonum
@la
Rispolept
@sr-el